Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H31NO |
| Molecular Weight | 253.4234 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCN1CCCC1=O
InChI
InChIKey=NJPQAIBZIHNJDO-UHFFFAOYSA-N
InChI=1S/C16H31NO/c1-2-3-4-5-6-7-8-9-10-11-14-17-15-12-13-16(17)18/h2-15H2,1H3
| Molecular Formula | C16H31NO |
| Molecular Weight | 253.4234 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| The influence of oxygen-containing functional groups on the dispersion of single-walled carbon nanotubes in amide solvents. | 2010-08-25 |
|
| Design of improved permeation enhancers for transdermal drug delivery. | 2009-11 |
|
| Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin. | 2008-11 |
|
| In vitro permeation study of hinokitiol: effects of vehicles and enhancers. | 2008-01 |
|
| Silicone elastomer uptake method for determination of free 1-alkyl-2-pyrrolidone concentration in micelle and hydroxypropyl-beta-cyclodextrin systems used in skin transport studies. | 2008-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:59:45 GMT 2025
by
admin
on
Mon Mar 31 18:59:45 GMT 2025
|
| Record UNII |
3P14VW8FNY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3P14VW8FNY
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
1368363
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | RxNorm | ||
|
300000052707
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
DTXSID4042206
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
2687-96-9
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
C065136
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
62459
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
3P14VW8FNY
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY | |||
|
146192
Created by
admin on Mon Mar 31 18:59:45 GMT 2025 , Edited by admin on Mon Mar 31 18:59:45 GMT 2025
|
PRIMARY |